Tokyo - Delayed Quote JPY

Alfresa Holdings Corporation (2784.T)

1,924.50
+4.50
+(0.23%)
At close: 3:30:00 PM GMT+9
Loading Chart for 2784.T
  • Previous Close 1,920.00
  • Open 1,900.00
  • Bid 1,923.00 x --
  • Ask 1,925.00 x --
  • Day's Range 1,897.00 - 1,930.50
  • 52 Week Range 1,897.00 - 2,473.50
  • Volume 483,800
  • Avg. Volume 543,831
  • Market Cap (intraday) 349.853B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 13.05
  • EPS (TTM) 147.46
  • Earnings Date Aug 4, 2025 - Aug 8, 2025
  • Forward Dividend & Yield 68.00 (3.54%)
  • Ex-Dividend Date Sep 29, 2025
  • 1y Target Est 2,173.33

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related businesses. The company was incorporated in 2003 and is based in Tokyo, Japan.

www.alfresa.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 2784.T

View More

Performance Overview: 2784.T

Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

2784.T
9.75%
Nikkei 225 (^N225)
7.29%

1-Year Return

2784.T
7.60%
Nikkei 225 (^N225)
4.22%

3-Year Return

2784.T
22.70%
Nikkei 225 (^N225)
38.32%

5-Year Return

2784.T
8.02%
Nikkei 225 (^N225)
81.41%

Compare To: 2784.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2784.T

View More

Valuation Measures

Annual
As of 5/21/2025
  • Market Cap

    349.03B

  • Enterprise Value

    208.68B

  • Trailing P/E

    13.01

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.12

  • Price/Book (mrq)

    0.72

  • Enterprise Value/Revenue

    0.07

  • Enterprise Value/EBITDA

    3.80

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.93%

  • Return on Assets (ttm)

    1.65%

  • Return on Equity (ttm)

    5.70%

  • Revenue (ttm)

    2.96T

  • Net Income Avi to Common (ttm)

    27.39B

  • Diluted EPS (ttm)

    147.46

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    177.09B

  • Total Debt/Equity (mrq)

    7.37%

  • Levered Free Cash Flow (ttm)

    -3.56B

Research Analysis: 2784.T

View More

Company Insights: 2784.T

Research Reports: 2784.T

View More

People Also Watch